Exceptional stereoselectivity in the synthesis of 1,3,4-trisubstituted 4-carboxy β-lactam derivatives from amino acids

Organic Letters

Volumn 9, Issue 8, 2007, Pages 1593-1596

  Pérez Faginas, Paula ^a   O'Reilly, Fran ^a   O'Byrne, Aisling ^a   García Aparicio, Carlos ^a   Martín Martínez, Mercedes ^a   De Jesus Perez Vega M ^a   Teresa Garcia Lopez M ^a   González Muñiz, Rosario ^a  

^a INSTITUTO DE QUÍMICA MÉDICA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BETA LACTAM; DIPEPTIDE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STEREOISOMERISM; SYNTHESIS;

AMINO ACIDS; BETA-LACTAMS; DIPEPTIDES; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; STEREOISOMERISM;

EID: 34247483127     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol070533d     Document Type: Article

References (36)

1. For recent reviews on the biological activity of β-lactams, see: (a) Singh, G. S. Mini-Rev. Med. Chem. 2004, 4, 69.
2. (b) Singh, G. S. Mini-Rev. Med. Chem. 2004, 4, 93.
3. (c) Veinberg, G.; Vorona, M.; Shestakova, I.; Kanepe, I.; Lukevics, E. Curr. Med. Chem. 2003, 10, 1741.
4. (d) Kidwai, M.; Sapra, P.; Bhushan, K. R. Curr. Med. Chem. 1999, 6, 195.
5. Sutton, J. C.; Bolton, S. A.; Hartl, K. S.; Huang, M.-H.; Jacobs, G.; Meng, W.; Ogletree, M. L.; Pi, Z.; Schumacher, W. A.; Seiler, S. M.; Slusarchyk, W. A.; Treuner, U.; Zalher, R.; Zhao, G.; Bisacchi, G. S. Bioorg. Med. Chem. Lett. 2002, 12, 3229.
6. Clemente, A.; Domingos, A.; Grancho, A. P.; Iley, J.; Moreira, R.; Neres, J.; Palma, N.; Santana, A. B.; Valente, E. Bioorg. Med. Chem. Lett. 2001, 11, 1065.
7. (a) Yoakim, C.; Ogilvie, W.; Cameron, D. R.; Chabot, C.; Guse, I.; Haché, B.; Naud, J.; O'Meara, J. A.; Plante, R.; Déziel, R. J. Med. Chem. 1998, 41, 2882.
8. (b) Gerona-Navarro, G.; Pérez de Vega, M. J.; García- López, M. T.; Andrei, G.; Snoeck, R.; De Clercq, E.; Baizarini, J.; González-Muñiz, R. J. Med. Chem. 2005, 48, 2612.
9. (c) Sperka, T.; Pitlik, J.; Bagossi, P.; Tözser, J. Bioorg. Med. Chem. Lett. 2005, 15, 3086.
10. Adlington, R. M.; Baldwin, J. E.; Becker, G. W.; Chen, B.; Cheng, L.; Cooper, S. L.; Hermann, R. B.; Howe, T. J.; McCoull, W.; McNulty, A. M.; Neubauer, B. L.; Pritchard, G. J. J. Med. Chem. 2001, 44, 1491.
11. Kvaerno, L.; Werder, M.; Hauser, H.; Carreira, E. M. J. Med. Chem. 2005, 48, 6035.
12. (a) Alcaide, B.; Almendros, P. Curr. Med. Chem. 2004, 11, 1921.
13. (b) Ojima, I.; Delaloge, F. Chem. Soc. Rev. 1997, 26, 377.
14. (a) Palomo, C.; Aizpurua, J. M.; Ganboa, I.; Benito, A.; Cuerdo, L.; Fratila, R. M.; Jiménez, A.; Loinaz, I.; Miranda, J. I.; Pytlewska, K. R.; Micle, A.; Linden, A. Org. Lett. 2004, 6, 4443.
15. (b) Khasanov, A. B.; Ramirez-Weinhouse, M. M.; Webb, T. R.; Thiruvazhi, M. J. Org. Chem. 2004, 69, 5766.
16. (c) Palomo, C.; Aizpurua, J. M.; Benito, A.; Miranda, J. I.; Fratila, R. M.; Matute, C.; Domercq, M.; Gago, F.; Martín-Santamaría, S.; Linden, A. J. Am. Chem. Soc. 2003, 125, 16243.
17. (d) Alonso, E.; López-Ortiz, F.; Del Pozo, C.; Peralta, E.; Macías, A.; González, J. J. Org. Chem. 2001, 66, 6333.
18. Singh, G. S. Tetrahedron 2003, 7631.
19. Palomo, C.; Aizpurua, J. M.; Ganboa, I.; Oiarbide, M. Curr. Med. Chem. 2004, 11, 1837.
20. Benaglia, M.; Cinquini, M.; Cozzi, F. Eur. J. Org. Chem. 2000, 563.
21. (a) France, S.; Weatherwax, A.; Taggi, A. E.; Lectka, T. Acc. Chem. Res. 2004, 37, 592.
22. (b) Magriotis, P. A. Angew. Chem., Int. Ed. 2001, 40, 4377.
23. Gerona-Navarro, G.; Bonache, M. A.; Herranz, R.; García- López, M. T.; González-Muñiz, R. J. Org. Chem. 2001, 66, 3538.
24. (a) Bonache, M. A.; Gerona-Navarro, G.; Martín-Martínez, M.; García-López, M. T.; López, P.; Cativiela, C.; González-Muñiz, R. Synlett 2003, 1007.
25. (b) Bonache, M. A.; Gerona-Navarro, G.; García-Aparicio, C.; Alías, M.; Martín-Martínez, M.; García-López, M. T.; López, P.; Cativiela, C.; González-Muñiz, R. Tetrahedron: Asymmetry 2003, 14, 2161.
26. (c) Bonache, M. A.; Cativiela, C.; García-López, M. T.; González-Muñiz, R. Tetrahedron Lett. 2006, 47, 5883.
27. (a) Kawabata, T.; Oztürk, O.; Suzuki, H.; Fuji, K. Synthesis 2003, 505.
28. (b) Kawabata, T.; Majumdar, S.; Tsubaki, K.; Monguchi, D. Org. Biomol. Chem. 2005, 3, 1609.
29. R: 5b = 9.75 min.
30. Sivaprakasam, M.; Couty, F.; Evano, G.; Srinivas, B.; Sridhar, R.; Rama Rao, K. Synlett 2006, 781.
31. Sivaprakasham, M.; Couty, F.; Evano, G.; Srinivas, B.; Sridhar, R.; Rao, K. M. ARKIVOC 2007, 71.
32. Full details of the coupling agents and bases used for the optimization of the synthesis of 9a are indicated in the Supporting Information.
33. Diastereoisomeric excess values: 9a (96%), 9b (92%), 10a (83%), 10b (81%), 11a (98%), and 11b (98%). Measured by HPLC.
34. For configurational assignments in dipeptide derivatives composed by one aliphatic and one aromatic amino acid, see: (a) González-Muñiz, R:; Cornille, F.; Bergeron, F.; Ficheux, D.; Pothier, J.; Durieux, C.; Roques, B. P. Int. J. Pept. Protein Res. 1991, 37, 331.
35. (b) Fournié-Zaluski, M. C.; Lucas-Soroca, E.; Devin, J.; Roques, B. P. J. Med. Chem. 1986, 29, 751.
36. The validity of these rules has unequivocally been demonstrated for a related dipeptide derivative composed by a Phe-derived β-lactam, without the 3-methyl substituent, and L-Ala-OMe: Gerona-Navarro, G.; García-López, M. T.; González-Muñiz, R. J. Org. Chem. 2002, 67, 3953.